In vitro binding and partitioning of irinotecan (CPT-11) and its metabolite, SN-38, in human blood
Development of target-based antineoplastic agents
Advanced non-small cell lung carcinoma : The emerging role of docetaxel
Gemcitabine in non-small cell lung cancer (NSCLC)
Current approaches and future strategies for pancreaticcarcinoma
Promising approaches in acute ieukemia
A Phase I trial of cisplatin plus decitabine, a new DNA- hypomethylating agent, in patients with advanced solid tumors and a follow-Up early Phase II evaluation in patients with inoperable non-small cell lung cancer
Instructions to Authors